Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria.
暂无分享,去创建一个
[1] B. Brüne,et al. Nitric oxide and its role in apoptosis. , 1998, European journal of pharmacology.
[2] B. Bloom,et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. , 1999, Science.
[3] D. Kwiatkowski,et al. 1,25-Dihydroxyvitamin D3 Induces Nitric Oxide Synthase and Suppresses Growth of Mycobacterium tuberculosis in a Human Macrophage-Like Cell Line , 1998, Infection and Immunity.
[4] C. Nathan,et al. Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Inducible Nitric Oxide Synthase : What Difference Does It Make ? , 2013 .
[5] D. Goldberg,et al. Regulation of the Salmonella typhimurium flavohemoglobin gene. A new pathway for bacterial gene expression in response to nitric oxide. , 1998, The Journal of biological chemistry.
[6] N. Boéchat,et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis , 1996, The Journal of experimental medicine.
[7] N. Hibler,et al. Response to Reactive Nitrogen Intermediates inMycobacterium tuberculosis: Induction of the 16-Kilodalton α-Crystallin Homolog by Exposure to Nitric Oxide Donors , 1999, Infection and Immunity.
[8] H. Whittle,et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. , 1999, The Journal of infectious diseases.
[9] F. Fang,et al. The transcriptional regulator SoxS is required for resistance of Salmonella typhimurium to paraquat but not for virulence in mice , 1997, Infection and immunity.
[10] F. Fang,et al. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Casanova,et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. , 1998, Science.
[12] A. Fischer,et al. Incidence, severity, and prevention of infections in chronic granulomatous disease. , 1989, The Journal of pediatrics.
[13] R. M. Simpson,et al. The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Newport,et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.
[15] E. N. Miller,et al. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[16] B. Hamilton,et al. Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[17] M. P. Gallagher,et al. The Salmonella typhimurium AhpC Polypeptide Is Not Essential for Virulence in BALB/c Mice but Is Recognized as an Antigen during Infection , 1998, Infection and Immunity.
[18] A. Zychlinsky,et al. The induction of apoptosis by bacterial pathogens. , 1999, Annual review of microbiology.
[19] Alfred Hausladen,et al. Nitrosative Stress: Activation of the Transcription Factor OxyR , 1996, Cell.
[20] F. Deist,et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.
[21] K. Chung,et al. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages , 2002 .
[22] C. Bogdan,et al. Type 1 Interferon (IFNα/β) and Type 2 Nitric Oxide Synthase Regulate the Innate Immune Response to a Protozoan Parasite , 1998 .
[23] P. Holt,et al. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. , 1998, Journal of immunology.
[24] S. Tannenbaum,et al. Roles of nitric oxide in inducible resistance of Escherichia coli to activated murine macrophages , 1995, Infection and immunity.
[25] B. Light,et al. Mycobacteriocidal Action of Exogenous Nitric Oxide , 1999, Antimicrobial Agents and Chemotherapy.
[26] V. Stewart,et al. Nitric oxide, nitrite, and Fnr regulation of hmp (flavohemoglobin) gene expression in Escherichia coli K-12 , 1996, Journal of bacteriology.
[27] E. Clementi,et al. Generation of Nitric Oxide by the Inducible Nitric Oxide Synthase Protects γδ T Cells from Mycobacterium tuberculosis-Induced Apoptosis , 1999, The Journal of Immunology.
[28] S. L. Chiang,et al. In vivo genetic analysis of bacterial virulence. , 1999, Annual review of microbiology.
[29] S. Cole,et al. Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis , 1997, Infection and immunity.
[30] S. Dorman,et al. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. , 1998, The Journal of clinical investigation.
[31] C. Nathan,et al. noxR3, a Novel Gene fromMycobacterium tuberculosis, Protects Salmonella typhimurium from Nitrosative and Oxidative Stress , 1999, Infection and Immunity.
[32] G. Storz,et al. Activation of the OxyR transcription factor by reversible disulfide bond formation. , 1998, Science.
[33] R. Döffinger,et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. , 1998, The Journal of clinical investigation.
[34] D. Malo,et al. Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg , 1993, Cell.
[35] O. Kwon. The role of nitric oxide in the immune response of tuberculosis. , 1997, Journal of Korean medical science.
[36] F. Fang,et al. Glucose 6-Phosphate Dehydrogenase Is Required forSalmonella typhimurium Virulence and Resistance to Reactive Oxygen and Nitrogen Intermediates , 1999, Infection and Immunity.
[37] Nitric oxide dioxygenase: an enzymic function for flavohemoglobin. , 1998 .
[38] L. Ting,et al. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.
[39] Simon Paul,et al. Mycobacterium tuberculosis Catalase and Peroxidase Activities and Resistance to Oxidative Killing in Human Monocytes In Vitro , 1999, Infection and Immunity.
[40] F. Heffron,et al. Recombination‐deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages , 1993, Molecular microbiology.
[41] J. Mudgett,et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Newport,et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. , 1996, The New England journal of medicine.
[43] L. Bossi,et al. Inducible prophages contribute to Salmonella virulence in mice , 1999, Molecular microbiology.
[44] S. Dorman,et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection , 1999, Nature Genetics.
[45] I. Charles,et al. Inducible nitric oxide synthase polymorphism and fatal cerebral malaria , 1998, The Lancet.
[46] P. Gros,et al. Natural Resistance to Infection with Intracellular Pathogens: The Nramp1 Protein Is Recruited to the Membrane of the Phagosome , 1997, The Journal of experimental medicine.
[47] S Falkow,et al. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[48] Clifton E. Barry,et al. Compensatory ahpC Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis , 1996, Science.
[49] C. Nathan,et al. Antimicrobial mechanisms of macrophages , 1992 .
[50] T. Eisenstein,et al. In Vivo Blockage of Nitric Oxide with Aminoguanidine Inhibits Immunosuppression Induced by an Attenuated Strain of Salmonella typhimurium, PotentiatesSalmonella Infection, and Inhibits Macrophage and Polymorphonuclear Leukocyte Influx into the Spleen , 1999, Infection and Immunity.
[51] A. Hausladen,et al. Nitrosative stress: metabolic pathway involving the flavohemoglobin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[52] B. Zwilling,et al. Role of Iron in Nramp1-Mediated Inhibition of Mycobacterial Growth , 1999, Infection and Immunity.
[53] A. Peitzman,et al. Essential Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response after Hemorrhagic Shock , 1998, The Journal of experimental medicine.
[54] H. Whittle,et al. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. , 1998, The New England journal of medicine.
[55] J. Foster,et al. Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[56] M. Dinauer,et al. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. , 1999, Immunity.
[57] G. Feng,et al. Nitric oxide regulates Th1 cell development through the inhibition of IL‐12 synthesis by macrophages , 1998, European journal of immunology.
[58] F. Fang. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. , 1997, The Journal of clinical investigation.
[59] T. Eisenstein,et al. Salmonella typhimurium Infection in Mice Induces Nitric Oxide-Mediated Immunosuppression through a Natural Killer Cell-Dependent Pathway , 1998, Infection and Immunity.
[60] C. Nathan,et al. A Novel Antioxidant Gene from Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.
[61] E. Medina,et al. How important is Nramp1 in tuberculosis? , 1998, Trends in microbiology.
[62] Lei Chen,et al. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. , 1998, Molecular cell.
[63] M. Dinauer,et al. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[64] M. Pallen,et al. Bacterial copper‐ and zinc‐cofactored superoxide dismutase contributes to the pathogenesis of systemic salmonellosis , 1997, Molecular microbiology.
[65] Stephan Nussberger,et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.
[66] T. Billiar,et al. Nitric Oxide Prevents IL-1β and IFN-γ-Inducing Factor (IL-18) Release from Macrophages by Inhibiting Caspase-1 (IL-1β-Converting Enzyme) , 1998, The Journal of Immunology.
[67] F. Fang,et al. DNA repair is more important than catalase for Salmonella virulence in mice. , 1995, The Journal of clinical investigation.
[68] C. Bogdan,et al. Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. , 1999, Science.
[69] S. Gordon. Phagocytosis : the host , 1999 .
[70] M. Rajandream,et al. Regulation of hmp Gene Transcription inMycobacterium tuberculosis: Effects of Oxygen Limitation and Nitrosative and Oxidative Stress , 1999, Journal of bacteriology.
[71] N. Andrews,et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene , 1997, Nature genetics.
[72] D. Goldberg,et al. Role for the Salmonella Flavohemoglobin in Protection from Nitric Oxide* , 1998, The Journal of Biological Chemistry.
[73] S. Grinstein,et al. Host Resistance to Intracellular Infection: Mutation of Natural Resistance-associated Macrophage Protein 1 (Nramp1) Impairs Phagosomal Acidification , 1998, The Journal of experimental medicine.
[74] Weinberg Jb. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. , 1998 .
[75] B. Lell,et al. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria , 1998, The Lancet.
[76] G. Church,et al. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[77] S. Ichiyama,et al. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages , 1997, Infection and immunity.